Autopsy report · NCT05091684
Administration of Fibrinogen Concentrate for Refractory Bleeding
Cause of deathSlow enrollment
“Only one patient was included in this study due to overly restrictive inclusion and exclusion criteria.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 5 months before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Sponsor type
- University, hospital or other
- Conditions
- Hematological Patients; Bleeding; Platelet Refractoriness
- Interventions
- Fibrinogen Concentrate Human
- Participants
- 1
- Sites
- 1
- Countries
- France
Trials that died the same way
- Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
“No patient corresponding to inclusion criteria couldn't be enrolled in the study” - Study of Viscosupplementation for the Treatment of Knee Pain After Menisectomy
“Patients did not meet inclusion criteria.” - Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations
“All patients during the study period were subjected to peripheral blocks or were excluded from the study due to exclusion criteria” - Bioavailability of Voriconazole
“no eligible patients; study stopped without inclusion” - Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
“Too narrow inclusion criteria. Impossible to recruit patients.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.